The mevalonate pathway, a metabolic target in cancer therapy

B Guerra, C Recio, H Aranda-Tavío… - Frontiers in …, 2021 - frontiersin.org
A hallmark of cancer cells includes a metabolic reprograming that provides energy, the
essential building blocks, and signaling required to maintain survival, rapid growth …

The YAP/TAZ pathway in osteogenesis and bone sarcoma pathogenesis

H Kovar, L Bierbaumer, B Radic-Sarikas - Cells, 2020 - mdpi.com
YAP and TAZ are intracellular messengers communicating multiple interacting extracellular
biophysical and biochemical cues to the transcription apparatus in the nucleus and back to …

[HTML][HTML] Simvastatin/hydrogel-loaded 3D-printed titanium alloy scaffolds suppress osteosarcoma via TF/NOX2-associated ferroptosis while repairing bone defects

Z **g, W Yuan, J Wang, R Ni, Y Qin, Z Mao, F Wei… - Bioactive materials, 2024 - Elsevier
Postoperative anatomical reconstruction and prevention of local recurrence after tumor
resection are two vital clinical challenges in osteosarcoma treatment. A three-dimensional …

[HTML][HTML] Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms

AF Hassanabad - Translational Lung Cancer Research, 2019 - ncbi.nlm.nih.gov
Statins have been shown to inhibit cell proliferation in vitro and tumor growth in animal
models. Various studies have also shown a decreased cancer-specific mortality rate in …

Effects of statins on brain tumors: a review

AR Afshari, H Mollazadeh, NC Henney… - Seminars in Cancer …, 2021 - Elsevier
Evidence from preclinical studies suggests that the competitive HMG-CoA reductase
(HMGCR) inhibitors universally known as' statins,'in addition to being powerful drugs that …

Increased pro-apoptotic and anti-proliferative activities of simvastatin encapsulated PCL-PEG nanoparticles on human breast cancer adenocarcinoma cells

M Dadashpour, M Ganjibakhsh, H Mousazadeh… - Journal of Cluster …, 2023 - Springer
Recently, Simvastatin (SIM) is received notable attention due to its anti-cancer properties.
However, the lipophilicity feature of SIM restricted its application as a chemotherapy agent …

The potential of isoprenoids in adjuvant cancer therapy to reduce adverse effects of statins

H Mo, R Jeter, A Bachmann, ST Yount… - Frontiers in …, 2019 - frontiersin.org
The mevalonate pathway provides sterols for membrane structure and nonsterol
intermediates for the post-translational modification and membrane anchorage of growth …

Statins: Complex outcomes but increasingly helpful treatment options for patients

N Mohammadkhani, S Gharbi, HF Rajani… - European Journal of …, 2019 - Elsevier
Statins are long known class of medicines and the most frequently prescribed drugs in
cardiovascular pharmacotherapy, widely ordered not only in patients suffering from …

Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma

SL Haney, D Feng, YS Chhonker… - Drug development …, 2023 - Wiley Online Library
Rab GTPases are critical regulators of protein trafficking in the cell. To ensure proper cellular
localization and function, Rab proteins must undergo a posttranslational modification …

Suppression of MET signaling mediated by pitavastatin and capmatinib inhibits oral and esophageal cancer cell growth

B Xu, T Muramatsu, J Inazawa - Molecular Cancer Research, 2021 - AACR
Despite increasing knowledge on oral and esophageal squamous cell carcinoma (OSCC
and ESCC), specific medicines against both have not yet been developed. Here, we aimed …